Work

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Year: 2021

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2021.04.016

Authors: Jeffrey A. Bogart, Xiaofei Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Laurie E. Gaspar, John V. Heymach, Michael Christian Dobelbower, Charles Kuzma, Thomas E. Stinchcombe, Everett E. Vokes

Institutions: SUNY Upstate Medical University, Duke University, Baylor College of Medicine, Banner MD Anderson Cancer Center, Banner MD Anderson Cancer Center at Banner North Colorado Medical Center, The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, FirstHealth of the Carolinas, Duke Medical Center, Duke Cancer Institute, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1065259983, G1327407074, Alliance Statistics and Data Management Center, G2509465741, G4185274752, NRG Oncology Network Group Operations Center, UG1 - NCTN (Network Lead), Alliance for Clinical Trials in Oncology Operations Center

OpenAlex ID: W3155206552

FWCI: 0.814

Cites: 8

Cited by: 15

Related to: 10